Related Experiment Video
Updated: May 18, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus
J Michelle Kahlenberg1, Mariana J Kaplan
1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-5680, USA. makaplan@umich.edu
Insights
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) increase cardiovascular disease risk. Understanding their shared inflammatory pathways is key to developing strategies to prevent heart complications in these autoimmune disorders.
Area of Science:
- Immunology
- Cardiology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases.
- Both RA and SLE share overlapping clinical features.
- Atherosclerotic cardiovascular disease (CVD) is a significant cause of morbidity and mortality in RA and SLE patients.
Purpose of the Study:
- To analyze mechanisms driving accelerated atherothrombosis in RA and SLE.
- To identify immune dysregulation pathways implicated in CVD risk.
- To explore preventive strategies for vascular complications in systemic autoimmunity.
Main Methods:
- Review of current literature on RA, SLE, and cardiovascular disease.
- Analysis of inflammatory pathways and immune dysregulation.
- Identification of potential therapeutic targets and preventive measures.
Main Results:
- Distinct inflammatory pathways and immune dysregulation contribute to CVD risk in RA and SLE.
- Shared mechanisms accelerate atherothrombosis in these conditions.
- Targeting these pathways may offer preventive strategies.
Conclusions:
- Inflammation and immune dysregulation are central to accelerated atherosclerosis in RA and SLE.
- Further research into specific pathways can guide the development of novel preventive strategies.
- Mitigating vascular complications requires a comprehensive approach addressing underlying autoimmunity.
Abstract:
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), the two most common systemic autoimmune disorders, have both unique and overlapping manifestations. One feature they share is a significantly enhanced risk of atherosclerotic cardiovascular (CV) disease that significantly contributes to morbidity and mortality. The primary mechanisms that drive CV damage in these diseases remain to be fully characterized, but recent discoveries indicate that distinct inflammatory pathways and immune dysregulation characteristic of RA and SLE likely play prominent roles. This review focuses on analyzing the major mechanisms and pathways potentially implicated in the acceleration of atherothrombosis and CV risk in SLE and RA, as well as in the identification of putative preventive strategies that may mitigate vascular complications in systemic autoimmunity.
Related Concept Videos
Atherosclerosis I: Introduction
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction
